Gilead Sciences to Present at Upcoming Investor Conferences

FOSTER CITY, Calif.--(BUSINESS WIRE)-- Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its executives will be speaking at the following investor conferences:

• SVB Leerink Global Healthcare Conference on Thursday, February 25, 2021 at 1:40 p.m. EST

• Cowen Annual Health Care Conference on Thursday, March 4, 2021 at 12:10 p.m. EST

The live webcasts can be accessed at the company’s investors page at investors.gilead.com. The replays will be available for at least 14 days following the presentation.

About Gilead Sciences

Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis and cancer. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California.

For more information on Gilead Sciences, please visit the company’s website at www.gilead.com, follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210218005325/en/

Jacquie Ross
Investor Relations
(650) 425-8408

Source: Gilead Sciences, Inc.

You May Also Be Interested In

• ETCAMAH® (camizestrant) in combination with a CDK4/6 inhibitor approved in the US for 1st-line advanced HR-positive breast cancer
• Eirion Risk Underwriters Launches New Inland Marine Program
• The Vector Gazette Launches Weekly AI Search Newsletter as Zero-Click Search Reshapes Marketing